Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Comparison of the efficacy and safety of Cresnon® and Crestor® in patients with hyperlipidemia

• 8-week, active-controlled, open-label, randomized, parallelgroup, fixed-dose, noninferiority, multicenter, phase 4 design

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dong-A ST Co., Ltd.
• Treatments: Rosuvastatin Calcium

Criteria

Inclusion Criteria:

• Age ≥ 20

• Persons who have not reached LDL-C targeted level in accordance with the treatment guidelines for dyslipidemia released by Korean Society of Lipidology and Atherosclerosis